Exscientia Holdings Limited (EXAI): Price and Financial Metrics


Exscientia Holdings Limited (EXAI): $11.80

1.13 (+10.59%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add EXAI to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

EXAI Stock Price Chart Interactive Chart >

Price chart for EXAI

EXAI Price/Volume Stats

Current price $11.80 52-week high $30.38
Prev. close $10.67 52-week low $6.56
Day low $10.53 Volume 104,000
Day high $11.82 Avg. volume 196,704
50-day MA $12.12 Dividend yield N/A
200-day MA $0.00 Market Cap 1.39B

Exscientia Holdings Limited (EXAI) Company Bio


Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. It offers end-to-end solution of artificial intelligence and technologies for target identification, drug candidate design, translational models, and patient selection. Its platform allows to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.


EXAI Latest News Stream


Event/Time News Detail
Loading, please wait...

EXAI Latest Social Stream


Loading social stream, please wait...

View Full EXAI Social Stream

Latest EXAI News From Around the Web

Below are the latest news stories about Exscientia plc that investors may wish to consider to help them evaluate EXAI as an investment opportunity.

Exscientia to Present at Upcoming Investor Conferences in March

OXFORD, England, February 22, 2022--Exscientia (Nasdaq: EXAI) today announced that Andrew Hopkins, DPhil., Exscientia’s founder and CEO and Ben Taylor, CFO & Chief Strategy Officer, will participate in fireside chats at the following investor conferences in March:

Yahoo | February 22, 2022

Is Exscientia PLC Sponsored ADR (EXAI) Stock Outpacing Its Medical Peers This Year?

Here is how Exscientia PLC Sponsored ADR (EXAI) and Henry Schein (HSIC) have performed compared to their sector so far this year.

Yahoo | February 9, 2022

Border to Coast Pensions Partnership Ltd Buys PayPal Holdings Inc, Big Lots Inc, Fiserv Inc, ...

Investment company Border to Coast Pensions Partnership Ltd (Current Portfolio) buys PayPal Holdings Inc, Big Lots Inc, Fiserv Inc, NOV Inc, Mastercard Inc, sells Peloton Interactive Inc, Alliance Data Systems Corp, Alibaba Group Holding, M&T Bank Corp, Canada Goose Holdings Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Border to Coast Pensions Partnership Ltd.

Yahoo | February 8, 2022

Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI

OXFORD, England, January 19, 2022--Professor Charlotte Deane, Ph.D., of the University of Oxford, has joined Exscientia as Chief Scientist of Biologics AI. In this newly created role, she will focus on the application of artificial intelligence (AI), machine learning, and the design of protein structures in the discovery and development of novel drug candidates.

Yahoo | January 19, 2022

Sanofi (SNY) Inks Deal to Develop AI-Driven Precision Medicines

Sanofi (SNY) signs a collaboration agreement with Exscientia to develop precision-engineered medicines in oncology and immunology using the latter's AI-driven platform.

Yahoo | January 10, 2022

Read More 'EXAI' Stories Here

EXAI Price Returns

1-mo 7.47%
3-mo -25.46%
6-mo -46.09%
1-year N/A
3-year N/A
5-year N/A
YTD -40.28%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6445 seconds.